CPT code 87500: VRE molecular test, amplified probe2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Amplified nucleic acid testing detects vancomycin-resistance markers in Enterococcus and is reported when a laboratory performs this molecular test.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide632.6K Medicare services in 2024

Medicare pays $35.09 for 87500 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$35.09

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2020
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 87500 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 87500 covers

This amplified probe assay detects nucleic acid associated with vancomycin resistance in Enterococcus, including vanA- and vanB-associated resistance. Clinical laboratories perform it to detect VRE. The assay targets resistance-associated nucleic acid rather than providing a culture-based susceptibility result.

Report the service for amplified nucleic acid detection of vancomycin resistance. Medicare pays code 87500 under the CLFS at one nationally set amount, with the same amount across states and localities and no office-versus-facility difference. The 2026 national amount is $35.09, unchanged from 2020 through 2026. The test is paid through the CLFS rather than the physician fee schedule.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 87500

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 87500. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 87500 with status X (excluded by statute), so the test itself is paid only from the CLFS.

87500 on the lab fee schedule since 2020

87500 · CLFS 2026 Q4 (current)

$35.09

Unchanged since Jan 1, 2020

Amount in each year’s latest CLFS release · bars start at $0

27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.

87500 compared with similar tests

87513H. pylori resistanceClarithromycin, amplified probe$35.09
Code 87513 detects clarithromycin resistance associated with H. pylori. Code 87500 detects vancomycin-resistance nucleic acid in Enterococcus.
87081Culture screenScreening only$6.63
Code 87500 uses amplified nucleic acid detection for vancomycin resistance; 87081 describes bacterial screening by culture.
87186Susceptibility testMicrodilution or agar dilution$8.65
Code 87500 detects resistance-associated nucleic acid. Code 87186 is used for antimicrobial susceptibility testing of a cultured isolate.

87500 billing questions

When should this code be selected instead of a culture-based screen?

Use this code for amplified nucleic acid detection of vancomycin resistance. A culture-based screen describes a different laboratory method.

What does the assay detect?

It detects nucleic acid associated with vancomycin resistance in Enterococcus, including vanA- and vanB-associated resistance.

Is this a susceptibility test on a cultured isolate?

No. This code describes amplified nucleic acid detection; susceptibility testing evaluates an isolate using a different method.

How does Medicare pay for this test?

Medicare pays it under the CLFS at one national amount across states and localities, without an office-versus-facility payment difference. The code is excluded from the physician fee schedule.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 87500PUF_CLFS_CY2026_Q4V1.csv, line 2,008 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 87500?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 87500 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist